AXR.NYSEAmrep CORP

Form 4: AMREP Director Cloues II Receives Stock Units

Sentiment:

Insider Transaction Report


AMREP Corp. Director Edward B. Cloues II was granted 1,595 deferred stock units, increasing his beneficial ownership to 24,408.56 units.

Summary

  • Edward B. Cloues II, a Director and 10% Owner of AMREP Corp. (AXR), acquired 1,595 deferred stock units.
  • The transaction date for the acquisition was December 31, 2025.
  • These deferred stock units vest immediately upon grant and represent the right to receive one share of AMREP's common stock per unit.
  • The shares will be distributed within 30 days after Cloues' termination of service as a director.
  • Following this transaction, Cloues beneficially owns 24,408.56 deferred stock units.

Sentiment

Score: 6

Explanation: Slightly positive due to increased insider alignment, but a routine compensation event with no immediate material impact on company operations or financials.

Positives

  • Increased alignment of a director's interests with shareholders through additional equity ownership.
  • The deferred stock units vest immediately upon grant, providing immediate equity interest.

Negatives

  • The grant of stock units, while non-cash, represents potential future dilution for existing shareholders when converted to common stock.
  • No direct cash investment by the insider, as the units were granted at a $0 price.

Risks

  • The Power of Attorney includes an indemnification clause for the Company and attorneys-in-fact against losses, claims, damages, or liabilities arising from untrue statements or omissions in information provided by the undersigned for SEC filings.

Future Outlook

The acquired deferred stock units will be distributed as shares of AMREP's common stock within 30 days after Edward B. Cloues II terminates his service as a director.

Industry Context

This is a standard insider compensation event, common across all industries for retaining and incentivizing directors and executives. It reflects a routine aspect of corporate governance and executive compensation structures.

Comparison to Industry Standards

  • This is a routine grant of deferred stock units to a director, a common practice in corporate compensation. Without specific details on AMREP's compensation philosophy or peer group comparisons, it is difficult to assess against specific industry benchmarks. However, equity grants are a standard component of director compensation across publicly traded companies, aiming to align director interests with long-term shareholder value.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of Attorney AuthorizationEdward B. Cloues II authorized Christopher V. Vitale and Adrienne M. Uleau to prepare, execute, and file Section 16 reports (Forms 4 and 5) on his behalf with the SEC.2025-10-22Streamlines the process for insider reporting compliance for the director.

Related Party Transactions

  • The grant of 1,595 deferred stock units to Edward B. Cloues II, a director of AMREP Corp., constitutes a related party transaction as it involves compensation from the company to an insider.

Stakeholder Impact

  • Shareholders: Potential minor future dilution upon conversion of deferred stock units to common stock. Increased alignment of director's interests with long-term shareholder value.
  • Director (Edward B. Cloues II): Receives additional equity compensation, increasing his stake in the company and aligning his financial interests with the company's performance.

Next Steps

  • Distribution of common stock shares to Edward B. Cloues II within 30 days after his termination of service as a director.

Key Dates

DateDescription
2025-10-22Date Edward B. Cloues II executed the Power of Attorney.
2025-12-31Date of transaction for the acquisition of deferred stock units.
2026-01-05Date the Form 4 was signed and filed.

Recommendation

hold

This Form 4 reports a routine grant of deferred stock units to a director as part of their compensation. While it increases insider ownership and aligns interests, it does not provide new fundamental information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It is a standard compensation event.

Keywords

AMREP Corp, AXR, Edward B. Cloues II, Director, Insider Transaction, Form 4, Deferred Stock Units, Equity Compensation, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.